title: Pressure mounts for companies to hand over data on antidiabetes drugs linked to pancreatic harm.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000818:Animals; D030881:Disclosure; D004345:Drug Industry; D052216:Glucagon-Like Peptide 1 / Q000037:antagonists & inhibitors*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D008402:Mass Media; D010190:Pancreatic Neoplasms / Q000139:chemically induced*; D010195:Pancreatitis / Q000139:chemically induced*; D018570:Risk Assessment; D013453:Sulfonylurea Compounds / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D052216:Glucagon-Like Peptide 1